- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05343533
Probiotic Administration on Mood (PAM)
Impact of Probiotic Administration on Mood, Psychological Traits, Physical Activity, Stress, and Sleep Quality
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
In recent years, the presence and awareness of a connection between the intestines and the brain has expanded leading to the understanding of developed communication pathways between the nervous, endocrine, and immune systems. Intestinal bacterial flora are active contributors to this axis through cellular signaling pathways and the release of immune system components, which fundamentally impact the function and action of various physiological systems. Interest in this area evolved through the understanding that various microbiota can produce neuroactive substances and neurotransmitters involved with the endocrine and autonomic nervous system pathways. This research has expanded to state that various bacterial products can influence cognitive functions, involving types of memory and problem-solving. Recent findings have begun to report on the impact that probiotic administration may have on mood, anxiety, and depression. Finally, recent work by Marotta et al. provided some of the first preliminary evidence that probiotic use may also impact mood and sleep quality. While initial work has developed this foundation, very little controlled research is available to help understand key contributing factors. For example, many key questions remain that future research should address to help better understand any impact probiotics may have on mood, depression, and anxiety. Some of these questions include:
Do all forms (genus, strain, etc.) of probiotics exert these impacts? How quickly do they exert impact? How large is the impact? Are certain aspect of affect more impacted than others? Once supplemented, how long is the residual impact (if there is any)? To help provided more guidance towards some of these basic research questions, this study is being proposed. The purpose of the study is to expand upon the previous work of Marotta et al. and determine the impact of probiotic administration on mood, depressive symptoms, anxiety, sleep quality, and other personality traits in a larger group of healthy men and women. This study will expand on the supplementation regimen and include a wider variety of hormonal assessments than what has previously been completed using this combination of probiotics.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Missouri
-
Saint Charles, Missouri, Estados Unidos, 63301
- Lindenwood University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- between the ages of 18 - 50 years
- has a body mass index between 18.5 - 30 kg/m2.
- Anyone with a body mass index between 30 - 32 kg/m2, but has a body composition <25% fat -for men and <35% for women will be accepted into the study
- has been weight stable for the past three months (defined as less than a 5% variation in body -mass over this time)
- is determined to be healthy through completion of a health history questionnaire
Exclusion Criteria:
- Are currently diagnosed or being treated for any cardiac, respiratory, endocrine, psychiatric, musculoskeletal, - renal, hepatic, neuromuscular or metabolic disease or disorder that in the judgement of the study participant's personal physician or research nurse that will preclude their safe participation or will contraindicate quality control over the collected data
- are currently diagnosed with or are being treated for celiac disease, lactose intolerance, digestive insufficiencies or other gastrointestinal complications such as irritable bowel syndrome, ulcerative colitis, etc.
- report having used anabolic steroids within the past 30 days
- report have used any illicit or recreational drugs within the past 30 days
- report the intake of any prescription or over-the-counter medications (i.e., antibiotics) that may impact study outcomes
- report the current use of any dietary supplements known to impact digestion or sleep quality for the past 30 days
- report already taking a probiotic within the past 30 days
- have been actively trying to lose weight
- are currently following a ketogenic or low carbohydrate diet within the past 30 days
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Active Probiotic
A mixture of probiotic strains (2.5 gram daily doses of 4 x 109 CFU/packet) of the following species (Lactobacillus fermentum, Lactobacillus rhamnosus, Lactobacillus plantarum, Bifidobacterium longum).
|
After baseline or initial testing, participants will be randomly assigned in a double-blind fashion to ingest on a daily basis for 6 weeks either a placebo or a probiotic supplement.
Identical follow-up measurements will then occur each visit after taking their assigned supplement.
After 6 weeks of administration, the supplementation protocol will stop and a final evaluation will be completed 3 weeks later (9 weeks after initial administration) to assess any residual impact of the assigned supplement after a 3-week washout.
|
Comparador de placebos: Placebo
Maltodextrin capsule
|
After baseline or initial testing, participants will be randomly assigned in a double-blind fashion to ingest on a daily basis for 6 weeks either a placebo or a probiotic supplement.
Identical follow-up measurements will then occur each visit after taking their assigned supplement.
After 6 weeks of administration, the supplementation protocol will stop and a final evaluation will be completed 3 weeks later (9 weeks after initial administration) to assess any residual impact of the assigned supplement after a 3-week washout.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Beck Depression Index II
Periodo de tiempo: 6 Weeks
|
The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression. Total Score Levels of Depression 0-10 = These ups and downs are considered normal 11-16 = Mild mood disturbance 17-20 = Borderline clinical depression 21-30 = Moderate depression 31-40 = Severe depression over 40 = Extreme depression |
6 Weeks
|
COPE Inventory
Periodo de tiempo: 6 weeks
|
The COPE Inventory is a multidimensional coping inventory to assess the different ways in which people respond to stress.
Five scales (of four items each) measure conceptually distinct aspects of problem-focused coping (active coping, planning, suppression of competing activities, restraint coping, seeking of instrumental social support); five scales measure aspects of what might be viewed as emotion-focused coping (seeking of emotional social support, positive reinterpretation, acceptance, denial, turning to religion); and three scales measuring coping responses that arguably are less useful (focus on and venting of emotions, behavioral disengagement, mental disengagement).
|
6 weeks
|
Leiden Index of Depression Sensitivity - Revised
Periodo de tiempo: 6 weeks
|
The Leiden Index of Depression Sensitivity (LEIDS) measures cognitive reactivity (CR) to sadness, an aspect of cognitive vulnerability to depression, conceptually similar to rumination.
A higher total score on all the subscales except acceptance and coping shows higher CR.
|
6 weeks
|
Pittsburgh Sleep Quality Index
Periodo de tiempo: 6 weeks
|
A self-rated questionnaire to assess sleep quality and disturbances 19 self-reported items Minimum score: 0; Maximum score: 21 Higher scoring indicated worse sleep quality |
6 weeks
|
State-Trait Anxiety Inventory form Y1 and Y2
Periodo de tiempo: 6 weeks
|
Measure of trait and state anxiety.
All items on the scale are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always").
Higher scores indicate greater anxiety.
The STAI is appropriate for those who have at least a sixth-grade reading level.
|
6 weeks
|
Behavioral Avoidance/Inhibition Scale
Periodo de tiempo: 6 weeks
|
A measure of motivation to approach goal-oriented outcomes.
Higher scores correspond to higher motivation to avoid goal oriented outcomes, lower scores indicate lower motivation to avoid goal-oriented outcomes.
|
6 weeks
|
Bowel Health Questionnaire
Periodo de tiempo: 6 weeks
|
Measure of bowel health.
Lower scores indicate lower number of GI disturbances and higher scores indicate higher number of GI disturbances
|
6 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Hours Asleep
Periodo de tiempo: 6 weeks
|
Total hours asleep each night as obtained through a fit bit activity monitor
|
6 weeks
|
Minutes Awake
Periodo de tiempo: 6 weeks
|
Total minutes awake each night as obtained through a fit bit activity monitor
|
6 weeks
|
Number of awakenings
Periodo de tiempo: 6 weeks
|
Number of times awakened each night as obtained through a FitBit activity monitor
|
6 weeks
|
Minutes of restlessness
Periodo de tiempo: 6 weeks
|
Total minutes of restlessness each night as obtained through a FitBit activity monitor
|
6 weeks
|
Number of times Restless
Periodo de tiempo: 6 weeks
|
Number of times restless each night as obtained through a FitBit activity monitor
|
6 weeks
|
Total time Awake and Restless
Periodo de tiempo: 6 weeks
|
Total minutes of time awake and restless each night as obtained through a FitBit activity monitor
|
6 weeks
|
Total time in Bed
Periodo de tiempo: 6 weeks
|
Total time in bed each night as obtained through a FitBit activity monitor
|
6 weeks
|
Calories Burned
Periodo de tiempo: 6 weeks
|
Total KCal burned on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Steps
Periodo de tiempo: 6 weeks
|
Total number of steps on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Distance
Periodo de tiempo: 6 weeks
|
Total distance traveled each day on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Minutes Sedentary
Periodo de tiempo: 6 weeks
|
Total minutes sedentary on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Minutes Lightly Active
Periodo de tiempo: 6 weeks
|
Total minutes Lightly active on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Minutes Fairly Active
Periodo de tiempo: 6 weeks
|
Total minutes Fairly active on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Minutes Very Active
Periodo de tiempo: 6 weeks
|
Total minutes Very active on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Active Calories
Periodo de tiempo: 6 weeks
|
Total minutes of active calories expended on average each day as obtained through a FitBit activity monitor
|
6 weeks
|
Body Composition
Periodo de tiempo: 6 weeks
|
DEXA derived fat mass and fat free mass and bodyfat percentage
|
6 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- IRB-19-212
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .